Pfizer sells interest in Standard Life RE fund


post-it-note-sold-546793-mPharmaceutical giant and investment firm Pfizer has reportedly sold its stake in a Standard Life real estate fund.

The firm is said to have sold its stake in Standard Life’s European Property Growth Fund, according to Secondaries Investor.

The fund aims to provide investors with exposure to direct continental European real estate through income-producing investments and development opportunities.

It has a target total return of 10 per cent a year, over a five-year period.

Copyright © 2014 AltAssets